MYPEPTIDEQUEST
Peptide Treatment Reviews
Evidence, regulatory status, intended use, risks, and access — reviewed using the same framework.
Only treatments with sufficient public evidence are included. Commercial links do not affect editorial conclusions.
Browse evidence-based reviews with regulatory status, known risks, and source context clearly identified.
Semaglutide
Chronic weight management and other labeled uses vary by product
FDA-approved drug for specific labeled indications
Strong — FDA-reviewed clinical program
Tirzepatide
Chronic weight management; other indications depend on the branded product
FDA-approved drug for specific labeled indications
Strong — FDA-reviewed randomized clinical program
Liraglutide
Chronic weight management or type 2 diabetes, depending on product
FDA-approved drug for specific labeled indications
Strong — FDA-reviewed clinical program
Teriparatide
Osteoporosis in certain patients at high risk for fracture
FDA-approved drug for specific osteoporosis indications
Strong — FDA-reviewed clinical program
Abaloparatide
Osteoporosis in certain adults at high risk for fracture
FDA-approved drug for specific osteoporosis indications
Strong — FDA-reviewed clinical program
Glucagon
Emergency treatment of severe hypoglycemia; other uses depend on product
FDA-approved drug in multiple product-specific forms
Strong — FDA-reviewed product-specific evidence
BPC-157
Investigational; no FDA-approved therapeutic indication
Not FDA-approved for human treatment
Insufficient human evidence
TB-500
Investigational; no FDA-approved therapeutic indication
Not FDA-approved for human treatment
Very limited human evidence
MOTS-C
Investigational; no FDA-approved therapeutic indication
Not FDA-approved for human treatment
Primarily preclinical; insufficient human exposure data
CJC-1295
Investigational; no FDA-approved therapeutic indication
Not FDA-approved for human treatment
Limited clinical data
Ipamorelin
Investigational; no FDA-approved therapeutic indication
Not FDA-approved for human treatment
Limited human trials; no approved indication
Research compounds
Unapproved compounds use education-only framing and Read the Evidence calls to action. They are not offered as ordinary consumer treatments.
MyPeptideQuest
Your evidence-first guide to peptide-based treatments. Information only. Not medical advice.